Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Get our free Health Check email Email * SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our Privacy notice
A man who was left struggling to speak and eat properly due to tongue cancer has renewed hope after starting a trial for a new “smart” jab.
Carl Walsh, 59, from Birmingham, was diagnosed with tongue cancer in May 2024 after his swollen mouth left him in agony.
But when his initial treatment was unsuccessful, he joined a trial at the Royal Marsden NHS Foundation Trust in July this year for a new type of cancer jab.
The triple-action therapy drug amivantamab
Continue Reading on The Independent
This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.